Related Experiment Video
Updated: Aug 8, 2026

Viral Tracing of Genetically Defined Neural Circuitry
Published on: October 17, 2012
Gamma interferon-like immunoreactive material in rat neurons: evidence against a close relationship to gamma
R Kiefer1, C A Haas, G W Kreutzberg
1Department of Neuromorphology, Max-Planck-Institute for Psychiatry, Martinsried, F.R.G.
Insights
A novel 60,000 mol. wt protein in rat neurons mimics gamma interferon (IFN-γ) but differs from lymphocyte-derived IFN-γ. This neuronal protein
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Gamma interferon (IFN-γ) is a key immunoregulatory peptide produced by activated lymphocytes.
- A gamma interferon-like immunoreactive molecule has been identified in rat neurons.
Purpose of the Study:
- To characterize the neuronal gamma interferon-like molecule.
- To determine its relationship to lymphocyte-derived gamma interferon.
Main Methods:
- Western blot analysis of spinal ganglia homogenates using specific antibodies.
- Immunocytochemistry to assess distribution.
- Northern blot analysis for mRNA detection.
- Functional studies following nerve injury.
Main Results:
- A 60,000 mol. wt band, distinct from recombinant gamma interferon, was detected in sensory and sympathetic ganglia.
- This protein was not glycosylated, was detergent-insoluble, and co-purified with cytoskeleton.
- No corresponding gamma interferon mRNA was found in spinal ganglia.
- Neuronal gamma interferon-like material showed differential regulation after nerve injury.
Conclusions:
- The neuronal gamma interferon-like molecule is distinct from lymphocyte-derived gamma interferon.
- Its function may not involve the control of major histocompatibility complex expression on glial cells.
Abstract:
Gamma interferon is a potent immunoregulatory peptide produced by activated lymphocytes. Recently, a gamma interferon-like immunoreactive molecule has been demonstrated immunohistochemically in subpopulations of rat neurons. We have now further characterized this molecule. Western blot analysis of spinal ganglia homogenates revealed a single 60,000 mol. wt band that was immunoreactive with monoclonal antibody DB1 directed against rat gamma interferon. A polyclonal antiserum and the monoclonal antibodies DB10 and DB12 failed to detect this band although all antibodies were able to label the major 18,000 mol. wt band of recombinant gamma interferon on the same blots. The 60,000 mol. wt band was selectively present in homogenates from primary sensory and sympathetic ganglia but was absent from the central nervous system and other peripheral organs, corresponding to the reported immunocytochemical distribution of gamma interferon-like immunoreactivity. The 60,000 mol. wt protein does not appear to be glycosylated. It could not be solubilized by detergents such as Triton X-100 and it co-purified with cytoskeleton-enriched preparations. At the nucleic acid level, Northern blot analysis using probes specific for rat gamma interferon mRNA failed to detect specific mRNA in rat spinal ganglia, whereas a strong 1.2 kb signal was detected in activated spleen cells. Functionally, gamma interferon-like immunoreactive material is strongly induced in superior cervical ganglion neurons after preganglionic axotomy of the sympathetic chain, but remains constant or slightly decreases in L5 spinal ganglion neurons after sciatic nerve transection. In contrast, major histocompatibility complex antigens are strongly induced on non-neuronal cells in both systems. We conclude that the neuronal gamma interferon-like immunoreactive material is clearly distinct from lymphocyte-derived gamma interferon and might not be involved in the control of major histocompatibility complex expression on glial cells.

